These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 4555831

  • 1. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract] [Full Text] [Related]

  • 3. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H, Chien CP, Cole JO.
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract] [Full Text] [Related]

  • 4. Methylphenidate in tardive dyskinesia.
    Fann WE, Davis JM, Wilson IC.
    Am J Psychiatry; 1973 Aug; 130(8):922-4. PubMed ID: 4577471
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract] [Full Text] [Related]

  • 6. The pharmacology of tardive dyskinesias.
    Klawans HL.
    Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H, Cole JO.
    Arch Gen Psychiatry; 1972 Dec; 27(6):824-7. PubMed ID: 4637899
    [No Abstract] [Full Text] [Related]

  • 8. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973 Dec; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 9. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
    Rubovits R, Klawans HL.
    Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
    [No Abstract] [Full Text] [Related]

  • 10. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS, Wodak J, Veale JL, Munro OR.
    Med J Aust; 1972 Nov 04; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract] [Full Text] [Related]

  • 11. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P, Robotti E, Nardini M.
    Boll Chim Farm; 1972 Oct 04; 111(10):610-5. PubMed ID: 4566407
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J, Orman J.
    Neurology; 1988 Mar 04; 38(3):391-4. PubMed ID: 3279337
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
    Pakkenberg H, Fog R.
    Arch Neurol; 1974 Nov 04; 31(5):352-3. PubMed ID: 4607088
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ, Cazzullo CL, Cocchi A, Denber HC, Freyhan FA, Klerman GL, Köknel O, Levine J, Saarma J, Sarteschi P, Vinar O, Wittenborn JR.
    Mod Probl Pharmacopsychiatry; 1970 Nov 04; 5():148-56. PubMed ID: 4949818
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.